Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Need quick income to settle debts? Explore these effective methods to boost your earnings and regain financial stability.
18,327 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
A 2x leveraged ETF tracking Nvidia fell 12% in a single session while Nvidia itself declined 6.2%, erasing roughly $2...
NVIDIA CEO Jensen Huang positioned the latest AI stock pullback as a buying opportunity, a stance that reminds invest...
A high-profile insider sale at Amplitude raises questions for investors. This guide breaks down what amplitude's co-f...
When a biotech company’s leader sells shares, it can raise questions for investors. This guide breaks down how to int...
A major tech giant has locked in a multi-year AI compute deal worth nearly $1 billion per month for Nvidia GPUs, outp...
Small-cap biotech Aethlon Medical faces a pivotal year in 2026. This guide breaks down what to watch in aethlon (aemd...
Investors brace for the first rate hike since 2023 as the Fed under new chair Kevin Warsh faces sticky inflation and ...
Aurora Cannabis faces a pivotal year in 2026. This guide breaks down what to expect in aurora (acb) 2026 earnings, ho...
When the tech market cools, patient investors can find real opportunities. This guide highlights two blue‑chip names ...
On June 12, the stock market today, june delivered a space-focused pivot as AST SpaceMobile fell after gains and Spac...
AI memory demand is reshaping a sleepy sector. Learn how to gain exposure to Samsung, Hynix, and Micron with a smart,...